13F HOLDINGS REPORT
GILEAD SCIENCES, INC.
Quarter ended Q1 2025 · Filed May 13, 2025 · Accession 0001123292-25-000217
Total Value
$1.18B
Positions
14
Other Managers
1
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARCELLX INC | ACLX | 6,720,803 | $440.9M | 37.32% |
| 2 | GALAPAGOS NV | GLPGF | 16,707,477 | $419.4M | 35.50% |
| 3 | ARCUS BIOSCIENCES INC | RCUS | 31,424,760 | $246.7M | 20.88% |
| 4 | ASSEMBLY BIOSCIENCES INC | ASMB | 2,209,471 | $21.1M | 1.79% |
| 5 | MERUS N V | N5749R100 | 452,527 | $19.0M | 1.61% |
| 6 | KYVERNA THERAPEUTICS INC | KYTX | 4,126,119 | $8.0M | 0.67% |
| 7 | TANGO THERAPEUTICS INC | TNGX | 4,854,443 | $6.7M | 0.56% |
| 8 | XILIO THERAPEUTICS INC | XLO | 9,105,451 | $6.6M | 0.56% |
| 9 | KALARIS THERAPEUTICS INC | KLRS | 723,273 | $5.8M | 0.49% |
| 10 | HOOKIPA PHARMA INC | HOOK | 1,875,945 | $2.0M | 0.17% |
| 11 | ALLOGENE THERAPEUTICS INC | ALLO | 1,156,689 | $1.7M | 0.14% |
| 12 | LEAP THERAPEUTICS INC | CYPH | 5,319,148 | $1.6M | 0.14% |
| 13 | IKENA ONCOLOGY INC | 45175G108 | 1,159,145 | $1.5M | 0.13% |
| 14 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 369,855 | $359,758 | 0.03% |